Drug profile · INN
methacycline hydrochloride
RONDOMYCIN
methacycline hydrochloride (RONDOMYCIN) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — methacycline hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
methacycline hydrochloride (RONDOMYCIN) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is methacycline hydrochloride?
methacycline hydrochloride (RONDOMYCIN) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for methacycline hydrochloride?
RONDOMYCIN is a marketed brand name for methacycline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methacycline hydrochloride?
methacycline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.